Ignyte Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $57.50M |
|---|---|
| IPO Date | Jan 28, 2021 |
| CEO | David I. Rosenberg; David J. Strupp, Jr. |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 21 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Peak Bio |
| Deal Announced | Apr 28, 2022 |
| Deal Size, $M | $205.38M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 25, 2022 |
| Amendment Vote | TBD |
| Closing Date | Nov 1, 2022 |
Formerly IGNY
PKBO
PKBOW
| Price | $0.02 |
|---|---|
| Last closing price | $2.56 |
| H/L, today | $0.02 / $0.02 |
| H/L, 52-week | $0.06 / $10.79 |
| Volume, today | 66,140 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.